Blood tests may predict early primary myelofibrosis in patients presenting with essential thrombocythemia

American Journal of Hematology

Volumn 87, Issue 2, 2012, Pages 203-204

  Carobbio, Alessandra ^a   Finazzi, Guido ^a   Thiele, Juergen ^b   Kvasnicka, Hans Michael ^c   Passamonti, Francesco ^d   Rumi, Elisa ^e   Ruggeri, Marco ^f   Rodeghiero, Francesco ^f   Luigia Randi, Maria ^g   Bertozzi, Irene ^g   Vannucchi, Alessandro M ^h   Antonioli, Elisabetta ^h   Gisslinger, Heinz ⁱ   Buxhofer Ausch, Veronika ⁱ   Gangat, Naseema ^j   Rambaldi, Alessandro ^a   Tefferi, Ayalew ^j   Barbui, Tiziano ^a  

^a OSPEDALI RIUNITI   (Italy)

^b UNIVERSITY OF COLOGNE   (Germany)

^c GOETHE UNIVERSITY   (Germany)

^d OSPEDALE DI CIRCOLO   (Italy)

^e UNIVERSITY OF PAVIA   (Italy)

^f SAN BORTOLO HOSPITAL   (Italy)

^g UNIVERSITY OF PADOVA   (Italy)

^h UNIVERSITY OF FLORENCE   (Italy)

ⁱ MEDICAL UNIVERSITY OF VIENNA   (Austria)

^j MAYO CLINIC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; LACTATE DEHYDROGENASE;

ALGORITHM; COHORT ANALYSIS; FEMALE; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LETTER; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MYELOID METAPLASIA; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; THROMBOCYTHEMIA;

BONE MARROW; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEMATOLOGIC TESTS; HEMOGLOBINS; HUMANS; L-LACTATE DEHYDROGENASE; MALE; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; PRIMARY MYELOFIBROSIS; ROC CURVE; THROMBOCYTHEMIA, ESSENTIAL; WORLD HEALTH ORGANIZATION;

EID: 84855932927     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.22241     Document Type: Letter

References (11)

1. Swerdlow S, Campo E, Harris N, et al., editors. WHO Classification of Tumours of Haematopoietic and Lympoid Tissues. Lyon, France: IARC Press; 2008.
2. Thiele J, Kvasnicka HM, Mullauer L, et al. Essential thrombocythemia versus early primary myelofibrosis: A multicenter study to validate the WHO classification. Blood 2011; 117: 5710-5718.
3. Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: Rationale and important changes. Blood 2009; 114: 937-951.
4. Thiele J, Kvasnicka HM. Chronic myeloproliferative disorders with thrombocythemia: A comparative study of two classification systems (PVSG, WHO) on 839 patients. Ann Hematol 2003; 82: 148-152.
5. Florena AM, Tripodo C, Iannitto E, et al. Value of bone marrow biopsy in the diagnosis of essential thrombocythemia. Haematologica 2004; 89: 911-919.
6. Gianelli U, Vener C, Raviele PR, et al. Essential thrombocythemia or chronic idiopathic myelofibrosis? A single-center study based on hematopoietic bone marrow histology. Leuk Lymphoma 2006; 47: 1774-1781.
7. Barbui T, Thiele J, Passamonti F, et al. Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study. J Clin Oncol 2011; 29: 3179-3184.
8. Tefferi A, Thiele J, Orazi A, et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: Recommendations from an ad hoc international expert panel. Blood 2007; 110: 1092-1097.
9. Altman DG, Bland JM. Diagnostic tests 3: Receiver operating characteristic plots. BMJ 1994; 309: 188-192.
10. Mandrekar JN. Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol 2010; 5: 1315-1316.
11. Altman DG, Bland JM. Diagnostic tests. 1: Sensitivity and specificity. BMJ 1994; 308: 1552-1557.